glp 1 side effects anxiety The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy Managing Side Effects of GLP-1

As levels dip, bones may weaken and joints stiffen, putting extra stress on the spine

This convenience not only enhances patient compliance but also reinforces the therapeutic outcomes, making long-acting agonists increasingly preferred in daily practice

If you choose to drink, our guide on drinking on semaglutide covers harm reduction strategies

It also lines up with the expected entry of additional weight loss products in 2027, including new options from Novo Nordisk and other manufacturers

The slowdown came fast, steadily, and relentlessly, as seen in Intuitives subsequent quarterly commentary: Q323: In bariatrics, we continued to see double digit growth albeit at a modestly lower growth rate compared to Q2 Q423: We saw a continued deceleration in growth throughout 2023, likely the result of the uptake of GLP-1 drugs. Q124: Bariatric procedure growth continued to moderate and was flat year-over-year